Home
Search
Study Topics
Glossary
|
|
|
|
|
Tracking Information | |
---|---|
First Received Date † | January 20, 2009 |
Last Updated Date | January 20, 2009 |
Start Date † | February 2008 |
Current Primary Outcome Measures † |
Treatment success rate defined as ability to successfully drain the pseudocyst and patient being relieved of symptoms [ Time Frame: 18 months ] [ Designated as safety issue: Yes ] |
Original Primary Outcome Measures † | Same as current |
Change History | No Changes Posted |
Current Secondary Outcome Measures † |
Quality of Life following treatment which will be assessed on a 3-month basis for 18-months using the SF-36 questionnaire [ Time Frame: 18 months ] [ Designated as safety issue: No ] |
Original Secondary Outcome Measures † | Same as current |
Descriptive Information | |
Brief Title † | Randomized Trial Comparing Endoscopy and Surgery for Pancreatic Cyst-Gastrostomy |
Official Title † | Randomized Trial Comparing Endoscopy and Surgery for Pancreatic Cyst-Gastrostomy |
Brief Summary | Patients with pancreatitis can develop inflammatory fluid collection around the pancreas called pseudocysts. Pseudocysts may cause abdominal pain when they are more than 6cm in size. These pseudocysts can be treated (drained) by surgery or by endoscopy. Both treatment options are the current standard-of-care at all institutions around the World. The aim of this study is to identify the better of the two techniques, surgery versus endoscopy, for treatment of patients with pancreatic pseudocysts. This will be done by comparing a) the treatment success rates b) quality of life of patients following treatment and c) cost associated with treatment, between both treatment modalities. |
Detailed Description | |
Study Phase | |
Study Type † | Interventional |
Study Design † | Treatment, Randomized, Open Label, Uncontrolled, Parallel Assignment, Safety/Efficacy Study |
Condition † | Pancreatic Pseudocysts |
Intervention † |
|
Study Arms / Comparison Groups |
|
Publications * | |
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline. |
|
Recruitment Information | |
Recruitment Status † | Recruiting |
Estimated Enrollment † | 30 |
Estimated Completion Date | November 2009 |
Estimated Primary Completion Date | June 2009 (final data collection date for primary outcome measure) |
Eligibility Criteria † | Inclusion Criteria:
Exclusion Criteria:
|
Gender | Both |
Ages | 19 Years to 85 Years |
Accepts Healthy Volunteers | No |
Contacts †† | |
Location Countries † | United States |
Expanded Access Status | |
Administrative Information | |
NCT ID † | NCT00826501 |
Responsible Party | Shyam Varadarajulu, University of Alabama at Birmingham |
Secondary IDs †† | |
Study Sponsor † | University of Alabama at Birmingham |
Collaborators †† | |
Investigators † | |
Information Provided By | University of Alabama at Birmingham |
Verification Date | January 2009 |
† Required WHO trial registration data element. †† WHO trial registration data element that is required only if it exists. |